Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

被引：0
|
作者：
Yoh Watanabe
Tomomaro Etoh
Eiji Koike
Yoshiaki Mizuno
Wei-Min Wang
Hiroshi Hoshiai
机构：
[1] Kinki University School of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2010年 / 15卷
关键词：
Recurrent ovarian cancer; Salvage therapy; Cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：468 / 471
页数：3
相关论文
共 50 条
  • [21] Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
    Vici, Patrizia
    Sergi, Domenico
    Pizzuti, Laura
    Mariani, Luciano
    Arena, Maria Grazia
    Barba, Maddalena
    Maugeri-Sacca, Marcello
    Vincenzoni, Cristina
    Vizza, Enrico
    Corrado, Giacomo
    Paoletti, Giancarlo
    Tomao, Federica
    Tomao, Silverio
    Giannarelli, Diana
    Di Lauro, Luigi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [22] TRABECTEDIN IN HEAVILY PRETREATED RECURRENT OVARIAN CANCER PATIENTS: A CASE-CONTROL STUDY
    Panici, P. Benedetti
    Marchetti, C.
    Musella, A.
    Romito, A.
    Vertechy, L.
    Lecce, F.
    Tomao, F.
    Di Donato, V.
    Perniola, G.
    Palaia, I.
    Muzii, L.
    Monti, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 638 - 638
  • [23] Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer
    Adam, Jean-Philippe
    Boumedien, Feriel
    Letarte, Nathalie
    Provencher, Diane
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 47 - 53
  • [24] Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer
    Sehouli, Jalid
    Papanikolaou, G.
    Braicu, E. -I.
    Pietzner, K.
    Neuhaus, P.
    Fotopoulou, C.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (04) : 1326 - 1333
  • [25] Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer
    Jalid Sehouli
    G. Papanikolaou
    E.-I. Braicu
    K. Pietzner
    P. Neuhaus
    C. Fotopoulou
    Annals of Surgical Oncology, 2012, 19 : 1326 - 1333
  • [26] Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients
    Gorumlu, G.
    Kucukzeybek, Y.
    Kemal-Gul, M.
    Karaca, B.
    Cosan-Terek, M.
    Karabulut, B.
    Sanli, U. A.
    Akman, L.
    Ozsaran, A.
    Dikmen, Y.
    Uslu, R.
    JOURNAL OF BUON, 2008, 13 (03): : 349 - 352
  • [27] Weekly topotecan as a salvage therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer
    Marinaccio, M.
    De Marino, E.
    Mele, E.
    Catacchio, R.
    Meo, D.
    Iezzoni, C.
    Conversano, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] COMBINATION THERAPY OF ORAL CYCLOPHOSPHAMIDE AND BEVACIZUMAB FOR PATIENTS WITH RECURRENT OVARIAN AND PERITONEAL CANCER
    Goto, M.
    Takimoto, Y.
    Isono, R.
    Yamashita, M.
    Onoue, M.
    Yoshioka, E.
    Tashima, R.
    Hori, K.
    Tsubamoto, H.
    Ito, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A126 - A126
  • [29] Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
    Badoux, Xavier C.
    Keating, Michael J.
    Wang, Xuemei
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Faderl, Stefan
    Burger, Jan
    Koller, Charles
    Lerner, Susan
    Kantarjian, Hagop
    Wierda, William G.
    BLOOD, 2011, 118 (08) : 2085 - 2093
  • [30] Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer
    Goto, Mayako
    Tsubamoto, Hiroshi
    Isono-Taniguchi, Roze
    Takimoto, Yumi
    Tashima, Lena
    Hori, Kensuke
    Ito, Kimihiko
    MEDICINE, 2023, 102 (08) : E32880
12345